STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
104
13F, latest reported quarter
What the filings say about RDVT
Insiders, 180 days
-$2.5M net sold
1 buyer · 4 sellers · 0% of sales under a 10b5-1 plan
Activist stakes (13D), 180 days
1 filing
Largest: 3.7% of the class
Red Violet insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Red Violet, Inc. insiders sold a net $2.5M of stock across 75 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Jan 12, 2024.
+3.6% median (+3.6% mean) 90-day return after 2 previous buys.
The trade is 8.8% of the 22,733 shares held after it.
No other insider bought within 30 days.
104 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director LIVEK WILLIAM PAUL bought about $143.0K of RDVT on Aug 27, 2026, the largest insider purchase at the company on our record; 104 funds added in the latest 13F quarter.
10 earlier Form 4 trades (code P or S) here by this insider (10 sales), the last on Nov 13, 2025.
The trade is 3.2% of the 155,889 shares held after it.
3 other insiders sold within 30 days.
104 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Information Officer DELL JEFFREY ALAN sold about $286.2K of RDVT on Jun 1, 2026; 3 other insiders sold within 30 days and 104 funds added in the latest 13F quarter.
10 earlier Form 4 trades (code P or S) here by this insider (10 sales), the last on Nov 13, 2025.
The trade is 3.1% of the 160,889 shares held after it.
3 other insiders sold within 30 days.
104 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Information Officer DELL JEFFREY ALAN sold about $288.1K of RDVT on Jun 1, 2026; 3 other insiders sold within 30 days and 104 funds added in the latest 13F quarter.
10 earlier Form 4 trades (code P or S) here by this insider (10 sales), the last on Nov 13, 2025.
The trade is 1.1% of the 557,273 shares held after it.
3 other insiders sold within 30 days.
104 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Dubner Derek sold about $343.4K of RDVT on Jun 1, 2026; 3 other insiders sold within 30 days and 104 funds added in the latest 13F quarter.
10 earlier Form 4 trades (code P or S) here by this insider (10 sales), the last on Nov 13, 2025.
The trade is 1.1% of the 563,273 shares held after it.
3 other insiders sold within 30 days.
104 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Dubner Derek sold about $345.7K of RDVT on Jun 1, 2026; 3 other insiders sold within 30 days and 104 funds added in the latest 13F quarter.
75 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
No insider has filed to sell. Watch this after a run-up.
RDVT mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Wasatch Micro Cap Value Fund
$16.7M position · as of 2026-06-30
4.3%
Wasatch Micro Cap Fund
$27.0M position · as of 2026-06-30
4.0%
Calamos Timpani Small Cap Growth Fund
$20.1M position · as of 2026-07-31
2.6%
Brown Capital Management Small Company Fund
$5.5M position · as of 2026-06-30
1.7%
Lord Abbett Micro-Cap Growth Fund
$3.3M position · as of 2026-07-31
1.6%
NORTH SQUARE KENNEDY MICROCAP FUND
$473.1K position · as of 2026-05-31
1.4%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Derek Dubner
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$2.1M
$3.5M
$2.1M
+147%
n/a
2024
$1.9M
$3.2M
$1.9M
+57%
n/a
2023
$1.7M
$1.4M
$1.6M
-13%
n/a
2022
$1.5M
-$992.2K
$1.4M
-42%
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
An activist crossed the 5% line with declared intent.
The record shows a net $2.5M sold by insiders over 180 days, 104 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$99.0M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM RDVT
FY Dec 2025
$90.3M
FY Dec 2024
$75.2M
FY Dec 2023
$60.2M
FY Dec 2022
$53.3M
FY Dec 2021
$44.0M
Jun 2026
$26.7M
Mar 2026
$25.8M
Dec 2025
$23.4M
Sep 2025
$23.1M
Jun 2025
$21.8M
Mar 2025
$22.0M
Dec 2024
$19.6M
Sep 2024
$19.1M
At each fiscal year end
Single quarter
Net margin, TTM
+16.5%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM RDVT
FY Dec 2025
+14.6%
FY Dec 2024
+9.3%
FY Dec 2023
+22.5%
FY Dec 2022
+1.2%
FY Dec 2021
+1.5%
Jun 2026
+18.6%
Mar 2026
+17.0%
Dec 2025
+12.0%
Sep 2025
+18.3%
Jun 2025
+12.3%
Mar 2025
+15.6%
Dec 2024
+4.4%
Sep 2024
+9.0%
At each fiscal year end
Single quarter
Free cash flow, TTM
$33.6M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM RDVT
FY Dec 2025
$28.8M
FY Dec 2024
$23.8M
FY Dec 2023
$14.9M
FY Dec 2022
$12.1M
FY Dec 2021
$8.7M
Jun 2026
$10.5M
Mar 2026
$6.5M
Dec 2025
$6.6M
Sep 2025
$10.0M
Jun 2025
$7.3M
Mar 2025
$5.0M
Dec 2024
$6.7M
Sep 2024
$7.2M
At each fiscal year end
Single quarter
Debt to equity
0.00x
LongTermDebt as filed 2021-12-31 (54 months older than the period end) (includes the current portion); equity 2026-06-30
Debt to equity RDVT
FY Dec 2025
0.00x
FY Dec 2024
0.00x
FY Dec 2023
0.00x
FY Dec 2022
0.00x
FY Dec 2021
0.00x
Jun 2026
0.00x
Mar 2026
0.00x
Dec 2025
0.00x
Sep 2025
0.00x
Jun 2025
0.00x
Mar 2025
0.00x
Dec 2024
0.00x
Sep 2024
0.00x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt to cover
Cash flow to debt RDVT
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+15.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity RDVT
FY Dec 2025
+14.0%
FY Dec 2024
+8.1%
FY Dec 2023
+17.2%
FY Dec 2022
+0.9%
FY Dec 2021
+1.2%
Jun 2026
+15.8%
Mar 2026
+14.4%
Dec 2025
+14.0%
Sep 2025
+11.6%
Jun 2025
+9.5%
Mar 2025
+9.9%
Dec 2024
+8.1%
Sep 2024
+5.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+14.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets RDVT
FY Dec 2025
+12.5%
FY Dec 2024
+7.3%
FY Dec 2023
+15.9%
FY Dec 2022
+0.8%
FY Dec 2021
+1.0%
Jun 2026
+14.5%
Mar 2026
+13.3%
Dec 2025
+12.5%
Sep 2025
+10.7%
Jun 2025
+8.8%
Mar 2025
+9.0%
Dec 2024
+7.3%
Sep 2024
+5.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+25.4%
operating income after a 14.8% effective tax rate, over LongTermDebt as filed 2021-12-31 (54 months older than the period end) (includes the current portion) plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital RDVT
FY Dec 2025
+22.1%
FY Dec 2024
+11.4%
FY Dec 2023
n/a
FY Dec 2022
+0.8%
FY Dec 2021
-3.1%
Jun 2026
+25.4%
Mar 2026
+21.6%
Dec 2025
+22.1%
Sep 2025
+17.8%
Jun 2025
+13.4%
Mar 2025
+14.0%
Dec 2024
+11.4%
Sep 2024
+7.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+16.6%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed RDVT
FY Dec 2025
+13.7%
FY Dec 2024
+9.0%
FY Dec 2023
+3.1%
FY Dec 2022
+0.5%
FY Dec 2021
-2.2%
Jun 2026
+16.6%
Mar 2026
+14.3%
Dec 2025
+13.7%
Sep 2025
+12.0%
Jun 2025
+10.4%
Mar 2025
+11.3%
Dec 2024
+9.0%
Sep 2024
+7.2%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
71.50x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing RDVT
FY Dec 2025
62.58x
FY Dec 2024
70.98x
FY Dec 2023
21.02x
FY Dec 2022
575.50x
FY Dec 2021
1,323.00x
Jun 2026
56.39x
Mar 2026
35.67x
Dec 2025
62.58x
Sep 2025
66.99x
Jun 2025
80.66x
Mar 2025
60.63x
Dec 2024
70.98x
Sep 2024
76.89x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$1.2B
market value at close 2026-10-23 on 2026-08-07 shares, plus LongTermDebt as filed 2021-12-31 (54 months older than the period end) (includes the current portion), minus cash 2026-06-30
Enterprise value RDVT
FY Dec 2025
$752.1M
FY Dec 2024
$462.8M
FY Dec 2023
$246.3M
FY Dec 2022
$288.0M
FY Dec 2021
$476.4M
Jun 2026
$849.0M
Mar 2026
$444.8M
Dec 2025
$752.1M
Sep 2025
$685.0M
Jun 2025
$647.8M
Mar 2025
$489.3M
Dec 2024
$462.8M
Sep 2024
$354.9M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+2.6%
TTM free cash flow over market value at close 2026-10-23
FCF yield RDVT
FY Dec 2025
+3.6%
FY Dec 2024
+4.8%
FY Dec 2023
+5.4%
FY Dec 2022
+3.8%
FY Dec 2021
+1.7%
Jun 2026
+3.7%
Mar 2026
+6.2%
Dec 2025
+3.6%
Sep 2025
+4.0%
Jun 2025
+3.8%
Mar 2025
+4.7%
Dec 2024
+4.8%
Sep 2024
+5.5%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.84x
P/E over trailing EPS growth of 85%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing RDVT
FY Dec 2025
0.80x
FY Dec 2024
n/a
FY Dec 2023
0.01x
FY Dec 2022
17.27x
FY Dec 2021
n/a
Jun 2026
0.66x
Mar 2026
0.63x
Dec 2025
0.80x
Sep 2025
0.60x
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
RDVT ranks highest on financial health (99th percentile) and profitability (80th), and lowest on institutional and government (54th), among Software & IT peers.
Profitability
80
Inputs
Return on equity+15.8% · 74 pct, sector of 286
Return on assets+14.5% · 87 pct, sector of 381
Return on invested capital+25.4% · 75 pct, sector of 78
Return on capital employed+16.6% · 85 pct, sector of 294
Financial health
100
Inputs
Debt to equity0.00x · 100 pct, sector of 288
Cash flow to debtno debt to cover
Growth
69
Inputs
Revenue growth, YoY+20.0% · 71 pct, sector of 480
Backlog growth, YoY+19.3% · 67 pct, sector of 182
Insider conviction
56
Inputs
Net Form 4 buying (codes P and S), 180d-$2.5M · 44 pct, sector of 285
Insider buyers, 180d1 · 69 pct, sector of 290
Institutional and government
54
Inputs
Funds adding, latest quarter104 · 54 pct, sector of 415
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
62
Inputs
Short interest, % of float+5.1% · 48 pct, sector of 530
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+6.6% · 75 pct, sector of 316
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
RDVT filings, in plain words
Are Red Violet insiders buying or selling RDVT?
In the 180 days to 2026-10-28, Red Violet insiders were net sellers, a net $2.5M: $143.0K of purchases and $2.6M of sales reported on Form 4, by 1 buyer and 4 sellers.
Read the full summary
In the 180 days to 2026-10-28, Red Violet insiders were net sellers of RDVT, a net $2.5M across purchases and sales reported on Form 4 by 1 buyer and 4 sellers. Sales outweighed purchases more than tenfold by value. None of the 8 insider sales was flagged as made under a Rule 10b5-1 plan. 1 activist Schedule 13D filing in the last 180 days declared an intent to influence the company, the largest for 3.7% of the class. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.